ITREAS can develop a publication strategy for you to ensure that your results reach the target audience with maximum impact, therewith contributing to patient care. Once your database in locked, ITREAS and the scientific leadership will analyse the results together with your representatives and will ensure that the primary and secondary findings are disseminated to the medical community in accordance with the publication strategy.
The scientific leadership can also support you during regulatory agency reviews, where our associates have first hand experience with submitting and presenting clinical trials results to both the FDA and EMA.
Our team and partners have published in first tier journals such as the New England Journal of Medicine and the Lancet and have presented clinical trials several times during late breaking sessions at medical conferences and international symposia.